Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Concentrix (CNXC) Shares Outstanding (Diluted Average) (2020 - 2025)

Historic Shares Outstanding (Diluted Average) for Concentrix (CNXC) over the last 6 years, with Q4 2025 value amounting to $63.0 million.

  • Concentrix's Shares Outstanding (Diluted Average) fell 316.87% to $63.0 million in Q4 2025 from the same period last year, while for Nov 2025 it was $63.0 million, marking a year-over-year decrease of 316.87%. This contributed to the annual value of $63.0 million for FY2025, which is 316.87% down from last year.
  • As of Q4 2025, Concentrix's Shares Outstanding (Diluted Average) stood at $63.0 million, which was down 316.87% from $63.4 million recorded in Q3 2025.
  • Concentrix's 5-year Shares Outstanding (Diluted Average) high stood at $65.8 million for Q1 2024, and its period low was $51.4 million during Q3 2023.
  • Moreover, its 5-year median value for Shares Outstanding (Diluted Average) was $52.1 million (2021), whereas its average is $57.0 million.
  • As far as peak fluctuations go, Concentrix's Shares Outstanding (Diluted Average) surged by 2780.71% in 2024, and later tumbled by 316.87% in 2025.
  • Quarter analysis of 5 years shows Concentrix's Shares Outstanding (Diluted Average) stood at $51.9 million in 2021, then decreased by 0.34% to $51.7 million in 2022, then rose by 4.39% to $54.0 million in 2023, then grew by 20.49% to $65.1 million in 2024, then fell by 3.17% to $63.0 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $63.0 million in Q4 2025, compared to $63.4 million in Q3 2025 and $63.7 million in Q2 2025.